Publication Name	World Journal of Hepatology
Manuscript ID	93516
Country	Mali

Received	2024-02-28 18:26
Peer-Review Started	2024-02-28 18:26
To Make the First Decision
Return for Revision	2024-04-29 19:42
Revised	2024-05-13 10:24
Second Decision	2024-06-06 02:48
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief	2024-06-06 07:43
Articles in Press	2024-06-06 07:43
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2024-06-12 02:45
Publish the Manuscript Online	2024-07-26 10:33

ISSN	1948-5182 (online)
Open Access	This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4. 0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: Https: //creativecommons. org/Licenses/by-nc/4. 0/
Copyright	© The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Gastroenterology & Hepatology
Manuscript Type	Editorial
Article Title	Interleukin-mediated therapies in liver diseases and comorbidity effects
Manuscript Source	Invited Manuscript
All Author List	Nouhoum Bouare and Jean Delwaide
ORCID	Author(s) ORCID Number Nouhoum Bouare http://orcid.org/0000-0002-8362-6740 Jean Delwaide http://orcid.org/0000-0001-7894-8123
Funding Agency and Grant Number
Corresponding Author	Nouhoum Bouare, DSc, PhD, Research Scientist, Senior Lecturer, Senior Researcher, Department of Quality, Hygien, Biosafety/Biosecurity and Pharmacovigilence, National Institute of Public Health, Hippodrome Rue Hamilcar Cabral Bamako, Bamako 1771, Mali. nouhoumsamakoro@yahoo.fr
Key Words	Cytokines; Interleukins; Liver diseases; Therapy; Comorbidity
Core Tip	IL-mediated monotherapy and synergistic treatment experiments are certainly interesting for scientific insights. Overcoming clinical trials challenges a fortiori linked to the liver-comorbid condition, new drugs development models are being experienced, such as dissecting the molecular subphenotypes which favour disease progression, promoting the precision medicine through multiomics analysis, and promoting the safe, long-lasting and effective antiviral formulations. However, a judicious exploitation of newly available data, and applying related-useful findings pertaining to comorbidity pathway and a multidisciplinary approach, should efficiently address liver diseases management in a short-term a fortiori to avoid long-term complications.
Publish Date	2024-07-26 10:33
Citation	<p>Bouare N, Delwaide J. Interleukin-mediated therapies in liver diseases and comorbidity effects . <i>World J Hepatol</i> 2024; 16(7): 980-989</p>
URL	https://www.wjgnet.com/1948-5182/full/v16/i7/980.htm
DOI	https://dx.doi.org/10.4254/wjh.v16.i7.980

Full Article (PDF)	WJH-16-980-with-cover.pdf
Manuscript File	93516_Auto_Edited-YJP.docx
Answering Reviewers	93516-answering-reviewers.pdf
Audio Core Tip	93516-audio.opus
Conflict-of-Interest Disclosure Form	93516-conflict-of-interest-statement.pdf
Copyright License Agreement	93516-copyright-assignment.pdf
Non-Native Speakers of English Editing Certificate	93516-non-native-speakers.pdf
Peer-review Report	93516-peer-reviews.pdf
Scientific Editor Work List	93516-scientific-editor-work-list.pdf
CrossCheck Report	93516-crosscheck-report.pdf